Abstract
There are risks inherent in failing to adequately treat major depression during pregnancy, and there are risks associated with antidepressant medication during pregnancy. Near the end of pregnancy, a partial dose taper may reduce the risk of neonatal adverse effects for women who can tolerate a brief period of subtherapeutic medication levels.
Original language | English (US) |
---|---|
Pages (from-to) | 323-324 |
Number of pages | 2 |
Journal | Journal of Clinical Psychiatry |
Volume | 69 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2008 |